Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.

Item

http://www.wikidata.org/entity/Q33704562

Q33704562

about

Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature.Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis.Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis.A case of sarcoidosis with interstitial lung disease mimicking clinically amyopathic dermatomyositis and rapidly progressive interstitial lung disease.Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients.Autoantibodies against TIF-1-γ and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility.Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease.Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report

P2860

Q21090635-FA0328BB-303A-488D-8A85-ECB46F4013E8 Q26798023-1EA8A3C0-3702-4290-9B57-2E0AECD3DF23 Q33814323-7038A3B4-226C-4161-AFEF-BFFFD6994887 Q35153832-2C5E9E56-EC65-44A1-A012-BC56679AF954 Q35153899-283A109D-D4E4-43CC-B31B-18300E91E3B7 Q36015534-A1793A51-C125-4CC5-BA61-53A650AE8D19 Q36245820-716989C8-86B9-4E81-A2F9-9925B887F92C Q36947409-27984139-06B0-4A32-8CF5-6F9A2EEDFA82 Q37053219-B7401ACB-BCD7-4DBD-A37C-129E1B2AB384 Q37704772-7B4D8079-810C-4892-9262-110FBC8F1677 Q37906737-58002259-A6DE-4274-BDF6-BB1AB412F0EE Q37938701-88AF8372-7872-4F69-8363-D612F9C28DFE Q37988393-E7ACCEFD-BDEF-4BC4-815B-060F9D7F5EBB Q38125957-660D71DC-8EE0-46E1-84D4-1730DCF63882 Q38408020-8DDC9219-4BE4-47E9-8F37-68A62D4AE241 Q38596370-1B01A3F0-52E7-4262-BA55-0C3B6FFF9690 Q38646384-9C55811C-A2EF-430F-A938-E5BBB04B4C63 Q40725508-0BB2F207-FBF9-45BF-9FF2-9773F91745CE Q41876423-340EEA5F-2CB2-4765-B6DC-6D4C3AA408CB Q44358439-18D33AB9-A0F9-4872-9D8B-2FA923FA6DFD Q45052982-0521F525-722D-4EDB-9A7A-7D340FD6F824 Q47160515-5ACBF39F-8F27-40F5-9569-34A5B1665B55 Q47235167-5A4ED342-3B23-4EC4-B713-3DD4269213EF Q48234140-0E51691E-B55A-4FF5-A043-8744B9C597B3 Q52597638-6F726650-3BCA-465A-BB2D-78A1C2D3F3D7 Q54540683-6FC34EB2-BBD3-4876-9AB4-BB40FF70268B Q57753902-06FF5860-DF2B-466F-9496-DE2DDC9AF21F

P2860

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.

Item

http://www.wikidata.org/entity/Q33704562

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu